SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-18-001305
Filing Date
2018-01-08
Accepted
2018-01-08 17:20:24
Documents
3
Group Members
GRI-CEL, S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13D a18-2354_1sc13d.htm SC 13D 212741
2 EX-1 a18-2354_1ex1.htm EX-1 10481
3 EX-2 a18-2354_1ex2.htm EX-2 50525
  Complete submission text file 0001104659-18-001305.txt   275218
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filed by) CIK: 0001438569 (see all company filings)

IRS No.: 000000000
Type: SC 13D
SIC: 2834 Pharmaceutical Preparations

Mailing Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000
Business Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000 34918060946
TiGenix NV (Subject) CIK: 0001581987 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9
Type: SC 13D | Act: 34 | File No.: 005-89730 | Film No.: 18517238
SIC: 2834 Pharmaceutical Preparations